Guggenheim Maintains Buy on Eli Lilly, Lowers Price Target to $1273

Benzinga Newsdesk www.benzinga.com Negative 73.9%

Neg 73.9% Neu 0% Pos 0%

Guggenheim analyst Seamus Fernandez maintains Eli Lilly (NYSE:LLY) with a Buy and lowers the price target from $1235 to $1273.